Evidence map›Paper›PMID 39133877›Full record

ArticleBlood advances2024

Histiocytosis of the orbit and its association with KRAS mutations.

Jasmine H Francis, Rebecca F Silverman, Julia Canestraro, Dana Bossert, David Della Rocca, Vaios Hatzoglou, David H Abramson, Eli L Diamond

Abstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jasmine H FrancisOphthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-7637-3108
Rebecca F SilvermanOphthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0009-0003-2066-5181
Julia CanestraroOphthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Dana BossertDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
David Della RoccaOphthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Vaios HatzoglouDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
David H AbramsonOphthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-0118-6391
Eli L DiamondDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-5456-5961

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Molecular Pathogenesis and Therapy of Systemic Histiocytic NeoplasmsR37CA259260 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Eli Lous Diamond · 2021 to 2026
$3.3M
NCI NIH HHS P30 CA008748NCI NIH HHS R37 CA259260
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HistiocytosisMutationProto-Oncogene Proteins p21(ras)FemaleHumansMaleOrbital DiseasesKRAS protein, humanProto-Oncogene Proteins p21(ras)

Identifiers

PMID39133877
PMCPMC11459899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.